1 zentiva nv half year results report 2005 st augustn i first highlights total sales up 5 6 from czk 188 million to 478 driven by 11 3 increase in pharma revenues 2 8 growth czech republic 67 poland 43 and russia with a significant acceleration the nd quarter 54 other central european markets as extends its geographic reach gross profit margin of 64 7 versus 63 for 2004 net 31 988 which represents diluted eps 25 91 free cash flow before acquisitions was 647 representing ebit conversion 47 ji? í michal chairman ceo said today s confirm clear strengths business model rapid that we continue achieve both value our on going investment extending marketing capabilities these progress have made newer such
